Literature DB >> 8083663

High levels of viral replication during acute hepatitis B infection predict progression to chronicity.

T L Fong1, A M Di Bisceglie, R Biswas, J G Waggoner, L Wilson, J Claggett, J H Hoofnagle.   

Abstract

To assess the pattern of development of serologic markers during acute hepatitis B, levels of HBsAg, HBeAg, and hepatitis B virus (HBV) DNA were assayed in stored serum samples obtained sequentially from 12 subjects infected with HBV during experimental studies conducted in the 1950s. Six patients developed acute self-limited hepatitis, three developed chronic hepatitis, and three had an asymptomatic infection without HBsAg. HBsAg was the first serologic marker detected (mean = 52 days after exposure), followed by HBeAg (62 days) and HBV DNA (72 days). Peak HBsAg levels occurred before onset of symptoms and correlated with peak titers of HBeAg and HBV DNA. Patients who developed chronic hepatitis had higher peak levels of viral markers than those with self-limited disease: HBsAg (30 versus 5.4 micrograms/ml), HBeAg (1:2,000 versus 1:60 titer) and HBV DNA (3,192 versus 444 pg/ml). Thus, chronic HBV infection is characterized by high levels of viral replication appearing early during the acute phase of infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083663     DOI: 10.1002/jmv.1890430210

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

Review 1.  Induced immunity against hepatitis B virus.

Authors:  Zeinab Nabil Ahmed Said; Kouka Saadeldin Abdelwahab
Journal:  World J Hepatol       Date:  2015-06-28

Review 2.  Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection.

Authors:  Kenichi Morikawa; Tomoe Shimazaki; Rei Takeda; Takaaki Izumi; Machiko Umumura; Naoya Sakamoto
Journal:  Ann Transl Med       Date:  2016-09

Review 3.  Innate immune targets of hepatitis B virus infection.

Authors:  Zhi-Qiang Zou; Li Wang; Kai Wang; Ji-Guang Yu
Journal:  World J Hepatol       Date:  2016-06-18

4.  Kinetics of acute hepatitis B virus infection in humans.

Authors:  S A Whalley; J M Murray; D Brown; G J Webster; V C Emery; G M Dusheiko; A S Perelson
Journal:  J Exp Med       Date:  2001-04-02       Impact factor: 14.307

Review 5.  Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases.

Authors:  Richard Sallie
Journal:  Virol J       Date:  2005-08-22       Impact factor: 4.099

6.  Determinants of viral clearance and persistence during acute hepatitis C virus infection.

Authors:  R Thimme; D Oldach; K M Chang; C Steiger; S C Ray; F V Chisari
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

Review 7.  Innate immune responses in hepatitis B virus (HBV) infection.

Authors:  Aurelia Busca; Ashok Kumar
Journal:  Virol J       Date:  2014-02-07       Impact factor: 4.099

Review 8.  Tolerance and immunity to pathogens in early life: insights from HBV infection.

Authors:  Michelle Hong; Antonio Bertoletti
Journal:  Semin Immunopathol       Date:  2017-07-06       Impact factor: 9.623

9.  The effect of treatment on pathogen virulence.

Authors:  Travis C Porco; James O Lloyd-Smith; Kimber L Gross; Alison P Galvani
Journal:  J Theor Biol       Date:  2004-11-13       Impact factor: 2.691

10.  Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China.

Authors:  H W Zhang; J H Yin; Y T Li; C Z Li; H Ren; C Y Gu; H Y Wu; X S Liang; P Zhang; J F Zhao; X J Tan; W Lu; S Schaefer; G W Cao
Journal:  Gut       Date:  2008-08-28       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.